Diamyd Medical AB (publ)

OM:DMYD B Stock Report

Market Cap: kr1.1b

Diamyd Medical Management

Management criteria checks 3/4

Diamyd Medical's CEO is Ulf Hannelius, appointed in Apr 2016, has a tenure of 8.08 years. total yearly compensation is SEK3.01M, comprised of 70.9% salary and 29.1% bonuses, including company stock and options. directly owns 0.23% of the company’s shares, worth SEK2.54M. The average tenure of the management team and the board of directors is 2.3 years and 20.3 years respectively.

Key information

Ulf Hannelius

Chief executive officer

kr3.0m

Total compensation

CEO salary percentage70.9%
CEO tenure8.1yrs
CEO ownership0.2%
Management average tenure2.3yrs
Board average tenure20.3yrs

Recent management updates

Recent updates

We're Keeping An Eye On Diamyd Medical's (STO:DMYD B) Cash Burn Rate

Feb 02
We're Keeping An Eye On Diamyd Medical's (STO:DMYD B) Cash Burn Rate

We Think Diamyd Medical (STO:DMYD B) Needs To Drive Business Growth Carefully

Sep 22
We Think Diamyd Medical (STO:DMYD B) Needs To Drive Business Growth Carefully

What You Need To Know About Diamyd Medical AB (publ)'s (STO:DMYD B) Investor Composition

Jan 22
What You Need To Know About Diamyd Medical AB (publ)'s (STO:DMYD B) Investor Composition

Here's Why Diamyd Medical's (STO:DMYD B) Statutory Earnings Are Arguably Too Conservative

Nov 30
Here's Why Diamyd Medical's (STO:DMYD B) Statutory Earnings Are Arguably Too Conservative

CEO Compensation Analysis

How has Ulf Hannelius's remuneration changed compared to Diamyd Medical's earnings?
DateTotal CompensationSalaryCompany Earnings
Feb 29 2024n/an/a

-kr120m

Nov 30 2023n/an/a

-kr116m

Aug 31 2023kr3mkr2m

-kr116m

May 31 2023n/an/a

-kr119m

Feb 28 2023n/an/a

-kr115m

Nov 30 2022n/an/a

-kr99m

Aug 31 2022kr3mkr2m

-kr104m

May 31 2022n/an/a

-kr91m

Feb 28 2022n/an/a

-kr106m

Nov 30 2021n/an/a

-kr83m

Aug 31 2021kr3mkr2m

kr60m

May 31 2021n/an/a

kr74m

Feb 28 2021n/an/a

kr99m

Nov 30 2020n/an/a

kr121m

Aug 31 2020kr3mkr2m

kr10m

May 31 2020n/an/a

kr13m

Feb 29 2020n/an/a

kr13m

Nov 30 2019n/an/a

-kr35m

Aug 31 2019kr2mkr1m

-kr37m

May 31 2019n/an/a

-kr38m

Feb 28 2019n/an/a

-kr43m

Nov 30 2018n/an/a

-kr42m

Aug 31 2018kr2mkr1m

-kr44m

May 31 2018n/an/a

-kr39m

Feb 28 2018n/an/a

-kr35m

Nov 30 2017n/an/a

-kr32m

Aug 31 2017kr2mkr906k

-kr26m

Compensation vs Market: Ulf's total compensation ($USD273.31K) is about average for companies of similar size in the Swedish market ($USD240.79K).

Compensation vs Earnings: Ulf's compensation has increased whilst the company is unprofitable.

CEO

Ulf Hannelius (48 yo)

8.1yrs

Tenure

kr3,006,000

Compensation

Mr. Ulf Hannelius, PhD, MBA, has been the Chief Executive Officer of Diamyd Medical AB (publ) since April 11, 2016 and serves as its President. Mr. Hannelius served as an Interim Chief Executive Officer at...

Leadership Team

NamePositionTenureCompensationOwnership
Ulf Hannelius
CEO & President8.1yrskr3.01m0.23%
SEK 2.5m
Anna Styrud
Chief Financial Officerno datano data0.13%
SEK 1.5m
Martina Widman
Chief Operating Officer1.9yrsno data0.012%
SEK 133.5k
Anton Lindqvist
Chief Scientific Officer6.7yrsno datano data
Eva Karlstrom
Chief Regulatory Affairs Officer2.3yrsno data0.0039%
SEK 42.7k
Christoph Nowak
Chief Medical & Business Officer2.3yrsno data0.0093%
SEK 101.5k
Maja Johansson
Chief Operating Officer of Manufacturing Site1.3yrsno data0.0024%
SEK 26.7k

2.3yrs

Average Tenure

48yo

Average Age

Experienced Management: DMYD B's management team is considered experienced (2.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Ake Lernmark
Member of the Scientific Advisory Board28.3yrsno datano data
David Leslie
Member of the Scientific Advisory Board25.3yrsno datano data
Daniel Kaufman
Member of the Scientific Advisory Board28.3yrsno datano data
Anders Essen-Möller
Independent Chairman28.3yrskr1.06m3.18%
SEK 34.8m
Mark Atkinson
Chairman of Scientific Advisory Board & Independent Director27.3yrskr175.00k0.016%
SEK 178.9k
Karin Hehenberger
Independent Director3.1yrskr125.00k0.0097%
SEK 106.7k
Erik Nerpin
Independent Vice Chairman12.3yrskr230.00k0.057%
SEK 627.2k
Torbjörn Bäckström
Independent Director7.3yrskr138.00k0.00097%
SEK 10.6k
Maria-Teresa Essen-Möller
Independent Director15.3yrskr164.00k1.33%
SEK 14.6m
Karin Rosen
Independent Director1.2yrskr28.00kno data

20.3yrs

Average Tenure

64.5yo

Average Age

Experienced Board: DMYD B's board of directors are seasoned and experienced ( 20.3 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.